首页 / 院系成果 / 成果详情页

A NOVEL COMBINATION REGIMEN OF PEGINTERFERON ALFA-2A AND ENTECAVIR RESULTS IN SUSTAINED POST-TREATMENT HBSAG CLEARANCE IN HBEAG-POSITIVE CHRONIC HEPATITIS B (CHB)  会议论文 期刊论文  

  • 编号:
    71f82628-ec0a-42e1-aad6-665ea83121a6
  • 作者:
    Sheng, Jifang[1,5];Bai, Xuefan[2];Wu, Shuhuan[3];Chen, Jianjie(陈建杰)[4]Sheng, Jifang[1,5];Xie, Yao[6];Chen, Chengwei[7];Jiang, Michael[8];Xie, Ding[1];
  • 语种:
    英文
  • 期刊:
    HEPATOLOGY ISSN:0270-9139 2011 年 54 卷 (1017A - 1017A) ; OCT
  • 收录:
  • 推荐引用方式
    GB/T 7714:
    Sheng Jifang,Bai Xuefan,Wu Shuhuan, et al. A NOVEL COMBINATION REGIMEN OF PEGINTERFERON ALFA-2A AND ENTECAVIR RESULTS IN SUSTAINED POST-TREATMENT HBSAG CLEARANCE IN HBEAG-POSITIVE CHRONIC HEPATITIS B (CHB) [J].HEPATOLOGY,2011,54:1017A-1017A.
  • APA:
    Sheng Jifang,Bai Xuefan,Wu Shuhuan,Chen Jianjie,&Xie Ding.(2011).A NOVEL COMBINATION REGIMEN OF PEGINTERFERON ALFA-2A AND ENTECAVIR RESULTS IN SUSTAINED POST-TREATMENT HBSAG CLEARANCE IN HBEAG-POSITIVE CHRONIC HEPATITIS B (CHB) .HEPATOLOGY,54:1017A-1017A.
  • MLA:
    Sheng Jifang, et al. "A NOVEL COMBINATION REGIMEN OF PEGINTERFERON ALFA-2A AND ENTECAVIR RESULTS IN SUSTAINED POST-TREATMENT HBSAG CLEARANCE IN HBEAG-POSITIVE CHRONIC HEPATITIS B (CHB)" .HEPATOLOGY 54(2011):1017A-1017A.
浏览次数:39 下载次数:0
浏览次数:39
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部